cal flow cell containing trapped sevelamer. Bile acid and oleic acid were pumped through the stirred cell in a manner designed rate limiting step in the synthesis of bile acids from heto mimic the in vivo situation. Binding was monitored by HPLC. tial total binding of bile acids, (2) an enhanced affinity for less hydrophobic bile acids, and (3) very slow bile acid release kinetics. These results support the hypotheSevelamer HCl, marketed under the trade name Renasis that the reductions in LDL cholesterol observed in gel (Genzyme Corp., Cambridge, MA, USA), is a crossclinical trials with sevelamer reflect the property of this linked, hydrophilic, water-swellable, cationic hydrogel cationic hydrogel to cooperatively bind bile acids and that has shown efficacy in reducing serum phosphate fatty acids. levels in hemodialysis patients [1] [2] [3] [4] . Chemically, sevelamer is a cross-linked polyallylamine polymer (Fig. 1) . METHODS Clinical studies in hemodialysis patients consistently have shown that, in addition to its primary function as Equilibrium binding: Experimental a phosphate sequestrant, sevelamer also significantly reFor binding isotherms obtained in the absence of oleduces low-density lipoprotein (LDL) cholesterol [2, 3, ate, the binding buffer contained 75 mmol/L sodium bi-5 -9] . A reduction in LDL cholesterol also was observed carbonate, 60 mmol/L sodium chloride, 8 mmol/L potasin healthy volunteers who were fed a controlled phossium chloride, 3 mmol/L sodium phosphate, 2 mmol/L phate diet [1] . Since sevelamer shares the non-absorbed magnesium chloride, and 2.5 mmol/L calcium chloride. cationic character of commercial bile acid sequestrants
The pH of the solution was adjusted into the range of 6.8 to 7.2 using 1 N HCl. Bile acid stock solution contained 15 mmol/L bile acid.
For the individual bile acid isotherms, this solution consisted of a single bile acid. For the mixed bile acid iso- therms, this solution consisted of 7.5 mmol/L cholyl glyBinding experiments were performed in the following manner: 30 Ϯ 3 mg of polymer was placed in 50 mL cine (GC), 3 mmol/L cholyl taurine (TC), 1.5 mmol/L chendeoxycholyl glycine (GCDC), 1.5 mmol/L deoxyflasks, to which 30 mL of buffer solution containing the appropriate amounts of bile acid, CHAPS and OA were cholyl glycine (GDC), 0.75 mmol/L chendeoxycholyl taurine (TCDC), and 0.75 mmol/L deoxycholyl taurine added (except for the CHAPS alone experiment, for which 15 mL was used). The 20% variation in polymer (TDC), to give final mole percents of 50:20:10:10:5:5 for GC:TC:GCDC:GDC:TCDC:TDC. This ratio was choweight is unlikely to be of significant consequence since the bound ligand was normalized against the polymer sen to mimic the bile acid distribution found in humans.
For binding isotherms performed in the presence of weight, and the free ligand was determined directly by HPLC. The flasks were then vortexed for approximately oleic acid, the binding buffer consisted of 100 mmol/L BES (N,N-bis [2-hydroxyethyl]-2-aminoethanesulfonic 30 seconds and shaken for at least 18 hours at 37ЊC and 355 rpm to produce a continuous uniform mixture of acid), 160 mmol/L NaCl and 20 mmol/L CHAPS {3-[(3-cholamidopropyl)-dimethylammonio]-1-propane sulfopolymer and bile acid solution. This time frame seemed sufficient, since Benson and colleagues demonstrated nate hydrate}. The addition of CHAPS, a zwitterionic bile acid derivative, ensured the aqueous solubility of that bile acids (GC, TC, GCDC, TCDC, GDC and TDC) equilibrate with cholestyramine within a one-hour time oleic acid. This buffer was adjusted to pH 6.8 with NaOH. The sodium salt of oleic acid was used to prepare 10 period under conditions similar to those reported here [12] . The pH was adjusted to the range of 6.8 to 7.2 using mmol/L solution of oleic acid (OA) by mixing it in BES buffer containing CHAPS and sonicating for 10 minutes 1 N HCl and the tube was shaken vigorously at 37ЊC for an additional two to three hours. Approximately 2 mL to dissolve the OA. The results of these fittings are given in Table 1 , and mula for each individual ligand:
will be discussed later (Discussion section). The presence of this amount of bile acid sufficed to For the separation of the bile acids and CHAPS, a solubilize the oleic acid. Platinum 100A 3-m column (Alltech) was used. The
The cylindrical flow cell had a total volume of about system was run isocratically with the same mobile phase 1.5 mL. Both ends of the cell were stoppered with 70 m as before except with a pH of 5.8. The higher pH value frits. A 25 m Teflon membrane (DuPont, Wilmington, was needed to separate the CHAPS peak from the GDC DE, USA) was clamped to the outlet side of the cell. A peak, which eluted at a similar time.
stirring bar in the middle of the cell was used to ensure For the separation of bile acids, CHAPS, and OA, a good mixing during the time-course of the flow experiPlatinum EPS 100A 3 m column (Alltech) was used.
ment. The dry weight of the polymer in the cell varied A gradient was run with mobile phase A being the mobile between 14.7 and 15.3 mg. phase as before (pH 5.8) and mobile phase B being 100%
The polymers were swollen in physiological buffer for methanol. Mobile phase A (100%) was run for 3.5 minmore than one hour before the experiment. During the utes. From 3.5 to 4.0 minutes a gradient up to 95% mobile experiment, the cells were immersed in a water bath at phase B was run. This was held constant until 7.0 minutes, 37ЊC, and positioned on top of magnetic stirrers. Prior at which time a gradient returned the mobile phase to to starting the experiment, physiological buffer was al-100% A at 7.1 minutes. The total run time was 10 minlowed to flow through the cell for 20 minutes. utes. The gradient with a higher amount of methanol Each experiment was separated into four continuous was needed to elute the oleic acid from the column.
stages, as summarized in Table 1 . For the experiments Equilibrium binding: Data analysis performed in the absence of oleic acid, stages 2 and 3 Equilibrium isotherms were fitted to the Hill equation:
were combined into a single 60-minute association phase. The mobile phases were controlled by HPLC. The The ϽC i Ͼ is measured in this experiment, and the C18 reverse phase column from Alltech with an inner concentration averaged from t iϪ1 to t i (t i ϭ t iϪ1 ϩ ⌬t i ). diameter of 7 mm. The temperature of the column was By summation we obtain: kept at 47ЊC. The flow rate of the mobile phase was 1.0 mL/min for internal HPLC injection, and 2.0 mL/
(Eq. 4) min for injection through the auto sampler. The detector was an evaporative light scattering detector, Sedex 55.
where Z is the total number of time intervals. Note that For this detector, the temperature was set at 40ЊC, the FCdt ϭ dN OUT can be written in differential form as: pressure at 1.7 bar, the manual gain at 7.0.
The injection volume was selected to maximize the C ϭ 1 F dN OUT dt (Eq. 5) oleic acid peak without saturating the detector. It was about 6 L for internal HPLC injection, 25 L for injecSince we knew N OUT versus t at intervals of ⌬t, C(t) was tion through the auto sampler.
obtained by differentiation of this curve. Substitution of Retention times were measured at 2.5 minutes, 3.25 C into equation 3 gave N B versus t. The only unknown minutes and 5.2 minutes for glycocholic acid (GC), glycoat this point was V F . Since the polymer was expected to deoxycholic acid (GDC), and oleic acid (OA), respectake up a negligible physical volume in the cell, this tively. The overall time window was about seven minutes quantity should be close to the physical cell volume. V F or less.
was obtained by fitting the concentration versus time Standard solutions were used to convert detector recurve obtained for the blank (which showed an exponensponse into bile acid concentrations. About ten standard bile acid and oleic acid solutions were prepared by half tial time constant for mixing that was equal to F V F ), and dilution of the stock 15 mmol/L solution. Data points found values in the range of 1.3 to 1.5 mL. (voltage vs. concentration) were fitted with a straight line passing through the coordinate origin.
RESULTS

Flow kinetics: Data analysis Equilibrium binding If t A is the time during which the ligand flows through
The equilibrium binding of individual bile acids to the cell (the association time), under our experimental sevelamer was examined in physiological buffer at 37ЊC. conditions, t A ϭ 60 minutes for all bile acids, and 30
As observed in our earlier study for bile acid binding to minutes for oleic acid. During this time a concentration other bile acid sequestrants [13], the binding behaviors C 0 (mmol/L) of ligand flows into the stirred cell at a rate of GCDC and GDC to sevelamer are indistinguishable, F (fixed at 0.25 mL/min). In our experiments, C 0 is fixed as are the binding behaviors of TCDC and TDC (data at 10.5 mmol/L GC, 4.5 mmol/L GDC, and 15 mmol/L not shown). Fits to equation 2 of the binding data for oleic acid. This association is followed by t D minutes of GC, TC, TCDC and GCDC binding to sevelamer are dissociation (t D ϭ 90 min for bile acids, and 120 min for shown in Figure 2 and are tabulated in Table 2 . Also oleic acid). After a total time of 150 minutes, a solution shown in Table 2 are the dissociation constants K d ϭ of MeOH/NH 4 OAc is pumped through for 30 minutes K (Table 2) . On the basis of saturation capacity (S max ) that have flowed into the cell; N OUT , total number of micromoles of bile acid that have flowed out of the cell; in mmoles bound per gram of polymer, the bile acid Table 2. curves are spline fits, and are presented as a visualization aid. Figures 2 and 3 , the binding of individual bile acids to sevelamer was quite different from the binding of bile acids in mixed bile acid solution. Whereas the individual bile acids showed distinct concen- Table 2 ), when monitored in a mixture, the concentration midpoints for the binding of the individual bile acids were all around 1 mmol/L (Fig. 3) . This point is made more clearly in Figure 4 where the data of Figure 3 were However, as a bile acid mixture was added to sevelamer containing 20 mmol/L CHAPS, binding of CHAPS inreplotted as the percent of a particular bile acid bound as a function of the free bile acid concentration. Note creased with bile acid binding and then leveled off and decreased slightly at higher bile acid concentrations. also that in both Figures 3 and 4 the data were plotted against the free bile acid concentration, which was the Note that the total CHAPS concentration was constant at 20 mmol/L, whereas the total bile acid concentration sum of the free (that is, unbound) bile acid concentrations of each of the individual bile acids. This result varied from 0 to 15 mmol/L. Hence, even in the presence of fatty acids, the bile acids bound with much greater demonstrates that the binding of the more hydrophobic dihydroxy bile acids (GDC, GCDC, TDC and TCDC) affinity to sevelamer than did CHAPS. The rationale for using CHAPS was to solubilize oleic cooperatively enhances the binding of the more hydrophilic trihydroxy bile acids (GC and TC).
acid in aqueous solution so that the effect of oleic acid on bile acid binding could be monitored. As shown in This cooperative effect is even more dramatic for the case of the binding of CHAPS, a zwitterionic bile acid Figure 6 , the presence of oleic acid dramatically enhanced bile acid binding at lower binding densities withanalog. As shown in Figure 5 , in the absence of added bile acid, no binding of CHAPS occurred to sevelamer. out greatly reducing the total bile acid binding capacity. chosen conditions were based on experimental results of the concentrations of bile salts and fatty acids in the gut [14] [15] [16] . Clearly, gastrointestinal transit times were highly variable in normal humans, and concentrations of fatty acid, bile acid association kinetics were rapid for of fatty acids and bile salts may have varied with diet.
both GC and GDC binding to sevelamer. Dissociation of The chosen conditions nonetheless allowed us to exam-GC also was rapid, so that by the end of the dissociation ine trends in behavior, even though we did not expect period, very little GC remained bound to sevelamer. them to be quantitatively predictive.
During the association part of this experiment, a soluFlow kinetics: Mixed bile acids in the presence tion of mixed bile acid (15 mmol/L total bile acid, 70% of fatty acid GC, 30% GDC) in physiological buffer was pumped at To more closely mimic in vivo conditions, flow cell 0.25 mL/min through a 1.3 mL volume mixing chamber studies were performed to examine the effect of oleic acid containing either buffer plus polymer gel or buffer alone on the kinetics of bile acid binding. The above experimen-(blank). The chamber was stirred and maintained at tal methodology was modified in the following manner: 37ЊC. Association occurred during the first 60 minutes.
During the association part of the experiment, a soluAfter 60 minutes, the dissociation phase began. At the tion of mixed bile acid (15 mmol/L total bile acid, 70% start of this phase, bile acid flow was stopped and buffer GC, 30% GDC) in physiological buffer was pumped at flow was started. Buffer was pumped through the cell 0.25 mL/min through a 1.3 mL volume mixing chamber for 90 minutes. At 60 ϩ 90 ϭ 150 minutes, the remaining containing either buffer plus sevelamer or buffer alone bound bile acid was removed from the polymer by flush-(blank). The chamber was stirred, and maintained at ing the cell with methanol/ammonium acetate. Hence, 37ЊC. During the first 30 minutes, association occurred at 20 minutes we were in the middle of the association in the presence of 15 mmol/L OA. During the next 30 phase. At 60 minutes, the association phase was comminutes, the cell was flushed with 15 mmol/L bile acid pleted, and the dissociation phase began. At 150 minutes, alone. After 60 minutes, the dissociation phase began. mass balance was verified by displacing bound bile acids At the start of this phase, bile acid flow was stopped, and (displacement phase). Results of these experiments are buffer flow was started. Buffer was pumped through the shown in Figure 7 , for selected time points.
These experiments demonstrated that, in the absence cell for 90 minutes. At 60 ϩ 90 ϭ 150 minutes, the In order to verify mass balance, the cell was then flushed with methanol/sodium acetate from 150 to 240 minutes, in order to displace residual bound bile acid. The length of the black bars gives the amount of GC bound, and the length of the light gray bars gives the amount of GDC bound. The total bound bile acid is equal to the sum of these two lengths. The dark gray bars correspond to the amount of oleic acid bound. Hence, the total ligand bound (bile acid plus oleic acid) is equal to the sum of all three lengths.
remaining bound ligand (bile acid ϩ oleic acid) was reunit of about 4 provides a good fit to the data. The size of this cooperative unit is comparable to that of a typical moved from the polymer by flushing the cell with methanol/ammonium acetate. bile acid micelle [17] . Hence, the picture arises of the association and cooperative binding of bile acid aggreThe results of this experiment are shown also in Figure 7 . It is clear from comparing the curves obtained gates within the polymer domain. As illustrated in Figure 2 , at between 5 and 8 mmole bile acid per gram of in the presence of OA to those in the absence of OA that OA competed for binding to sevelamer during the polymer, the binding capacity of sevelamer for bile acids is quite high. For comparison, the intrinsic binding capacassociation phase, and thus modestly reduced the total amount of bile acid bound during association. The most ity of cholestyramine has been estimated at about 3 to 6 mmoles per gram [18] [19] [20] . However, the total binding dramatic effect, however, was that the otherwise rapid dissociation of GC was significantly retarded by the prescapacity is only one of several parameters that may ultimately determine the biological efficacy of a bile acid ence of oleic acid. As a consequence of this effect, by the end of the dissociation phase there was a significant sequestrant. In fact, it has been argued that the efficacy of a bile acid sequestrant may reflect in large part its amount of GC bound in the presence of oleic acid, but no measurable GC bound in the absence of oleic acid.
ability to bind the less hydrophobic bile salts, in particular GC [12, 21, 23] . This hypothesis is supported by the As a consequence of the enhanced binding of GC, the total amount of bile acid bound at the end of the dissociaclinical data of Dam et al [23] . These data showed that, for six patients treated with 400 mg/kg per day of cholesttion phase also was significantly greater in the presence of oleic acid than in the absence.
yramine, the molar percentage of GC to total bile acid in human bile increased greatly in all cases. On average, this percentage increased from 27 to 55% after three DISCUSSION weeks of treatment, and further to 61% after six weeks Sevelamer binds bile acids cooperatively and of treatment. Furthermore, for these six patients, the with a high capacity average ratio of trihydroxy to dihydroxy bile acid increased from 0.63 to 1.6 after three weeks of treatment, The sigmoidal binding curves shown in Figure 2 Nonetheless, it should be recognized that in vivo, GC affinity of sevelamer for GC is rather weak, the presence is likely to be released from a polymer that has been of even trace amounts of more hydrophobic (dihydroxy) pre-loaded with fatty acids. As also shown in Figure 7 , bile acids can dramatically enhance GC binding at low under such conditions in vitro, GC release from sevebinding densities. The picture that emerges is of cooperalamer is dramatically slowed. In contrast to the situation tive binding of mixed bile acid micelles. Even more drain the absence of fatty acid, where no residual GC bindmatic is the ability of saturating quantities of fatty acid ing could be discerned following the dissociation period, to facilitate the binding of all bile acids, including GC in the presence of oleic acid, GC binding is comparable (Fig. 6) . In contrast, fatty acids compete with bile acids to GDC binding. Hence, the data suggest the intriguing for binding to more conventional bile acid sequestrants, hypothesis that the presence of fatty acid can actually and may play a dominant role in limiting the efficacy of enhance the ability of sevelamer to hold on to trihydroxy cholestyramine [24] .
bile acids in vivo as well as in vitro. Other factors present in the GI tract also may influence bile acid binding to sevelamer. For example, phosphotiConclusions dylcholine could compete with bile acids for binding.
Equilibrium binding properties. As for previously studVariations from neutral pH are possible. However, since ied bile acid sequestrants, the binding strength of the active transport of bile acids occurs at the terminal ileum, naturally occurring bile acids to sevelamer follows the pH variations would have to occur prior to passage into order: TCDC ϭ TDC Ͼ GCDC ϭ GDC Ͼ Ͼ TC Ͼ GC. the colon from the terminal ileum in order to influence This ordering reflects a dominant preference of all sesignificantly the efficacy of sevelamer as a bile acid sequestrants for more hydrophobic bile acids (dihydroxy questrant. In any case, the effective pKa of sevelamer vs. trihydroxy), and a minor but still significant prefershould be about 9.5, based on unreported measurements ence for taurine-conjugated bile acids compared to glythat we have performed on a closely related cross-linked cine-conjugate bile acids. However, for sevelamer, this polyallylamine polymer, and even at pH 8.0, which could preference is essentially nullified in mixed bile salt soluoccur in the distal colon [25] , about 75% of the amines tion due to the cooperative nature of bile acid binding. on this polymer should be fully protonated.
Cooperative interactions. Sevelamer shows cooperative binding isotherms that are well fitted by equation 2 In the absence of fatty acids, sevelamer with N ϭ 4. In mixed solutions of bile acids, at low releases GC very rapidly binding densities, the presence of more hydrophobic bile As Benson and colleagues have shown, trihydroxy bile acids facilitates the binding of more hydrophilic bile acids are released rapidly from cholestyramine on the acids. Most dramatically, the presence of saturating time-scale of transit through the gastrointestinal tract [12] .
quantities of oleic acid strongly facilitates the binding Combining this observation with the intrinsic poor affinof bile acids at low binding densities, without greatly ity of cholestyramine for trihydroxy bile acids provides diminishing total binding capacity. a plausible hypothesis for the relatively poor clinical poBile acid binding dynamics. In the absence of oleic tency of this bile acid sequestrant. As clinical studies acid, sevelamer binds bile acids rapidly, and releases GC have shown, prolonged treatment with cholestyramine very rapidly. In contrast, flow measurements performed would over time result in a perturbation of the biliary in the presence of oleic acid show a marked decrease in bile acid pool toward one richer in trihydroxy bile salts, the GC dissociation rate. Under these conditions, even GC in particular [23] . Since cholestyramine binds GC at the end of the dissociation period, the amount of GC with weak affinity, and releases it rapidly, this perturbabound per gram of polymer is comparable to the amount tion should result in a decrease in the ability of a given of GDC bound. dose of cholestyramine to bind bile acid over time, and
Comparison with clinical results. These studies demthus in reduced clinical efficacy. The experiment shown onstrate that sevelamer effectively binds bile acids in in Figure 7 and described above was designed to mimic vitro, under a variety of conditions. The high binding the time-dependent concentrations to which a sequescapacity and the favorable cooperative interactions trant would be exposed as it traversed the gastrointesamong bile acids and fatty acids for binding to this polytinal tract [26] . As shown in Figure 7 , in the absence of mer suggest a significant potential as a bile acid sequesfatty acid, there was a very rapid release of GC from trant. This potential may in turn explain the favorable sevelamer. Hence, to the extent that GC release kinetics lipid lowering effects of sevelamer in hemodialysis patients and in healthy volunteers [1] [2] [3] [5] [6] [7] [8] [9] . are dominant, our results suggest that sevelamer might
